Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain): An echocardiographic study

International Journal for Parasitology

Volumn 32, Issue 2, 2002, Pages 207-215

  Chandra, Madhulika ^a   Shirani, Jamshid ^a   Shtutin, Vitaliy ^a   Weiss, Louis M ^a   Factor, Stephen M ^a   Petkova, Stefka B ^a   Rojkind, Marcos ^a   Dominguez Rosales, Jose A ^a   Jelicks, Linda A ^a   Morris, Stephen A ^a   Wittner, Murray ^a   Tanowitz, Herbert B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Chagas' disease; Echocardiography; Trypanosoma cruzi; Verapamil

Indexed keywords

VERAPAMIL;

PARASITOLOGY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CHAGAS DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE WALL; HEART MUSCLE; HEART MUSCLE INJURY; HEART PROTECTION; HEART RIGHT VENTRICLE FUNCTION; HISTOLOGY; MALE; MOUSE; NONHUMAN; RODENT; STRAIN DIFFERENCE; TRANSTHORACIC ECHOCARDIOGRAPHY; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CARDIOTONIC AGENTS; CHAGAS DISEASE; COLLAGEN; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; HISTOCYTOCHEMISTRY; MALE; MICE; MYOCARDIUM; TRYPANOSOMA CRUZI; VENTRICULAR FUNCTION; VERAPAMIL;

MURINAE; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0036151241     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(01)00320-4     Document Type: Article

References (39)

1. Modulation of chemokine production and inflammatory responses in interferon-γ and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infections
2. Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemia
3. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
4. Differential regulation of nitric oxide synthase isoforms in experimental acute chagasic cardiomyopathy
5. Prevention of cardiomyopathy in mouse model lacking the smooth muscle sarcoglycan-sarcospan complex
6. Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of myocardial necrosis
7. Abnormalities of the coronary microcirculation in acute murine Chagas' disease
8. Alpha and beta-adrenergic blocking drugs
9. Infection of endothelial cells with Trypanosoma cruzi activates NF-κB and induces vascular adhesion molecule expression
10. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice
11. Application of cardiac gated magnetic resonance imaging in murine Chagas' disease
12. Autoimmunity in Chagas heart disease
13. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections
14. Verapamil ameliorates clinical pathological and biochemical manifestations of experimental chagasic cardiomyopathy in mice
15. Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters
16. A histopathological analysis of the course of myocarditis in C3H/He mice infected with Trypanosoma cruzi clone Sylvio-X10/4
17. Studies of Trypanosoma cruzi clones in inbred mice. III. Histopathological and electrocardiographical responses to chronic infection
18. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection
19. The role of endothelin in the pathogenesis of Chagas' disease
20. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease
21. Aortic endothelial cell changes in the acute septicemic phase of experimental Trypanosoma cruzi infection in rats: Scanning and transmission electron microscopic study
22. Coronary microvascular abnormalities in Chagas' disease
23. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
24. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
25. Gated magnetic resonance imaging of normal and hypertrophied murine hearts
26. Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy
27. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: Tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi
28. Effect of verapamil on the development of chronic Chagas' disease
29. Enhanced platelet adherence and aggregation in Chagas' disease: A potential pathogenic mechanism for cardiomyopathy
30. Chagas' disease
31. Compromised microcirculation in acute murine Trypanosoma cruzi infection
32. Effects of verapamil on acute murine Chagas' disease
33. The putative mechanistic basis for the modulatory role of endothelin-1 in the altered vasculator tone induced by Trypanosoma cruzi
34. Parasite persistence in the etiology of Chagas' disease
35. A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis
36. Trypanosoma cruzi induces endothelin release from endothelial cells
37. Selective inhibition of vascular cell adhesion molecule-1 expression by verapamil in human vascular endothelial cells
38. Echocardiographic assessment of cardiac function in conscious and anesthetized mice
39. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B2 kinin receptor gene knock out mice